Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Aug 11, 2009

Premium

Sequenom has named Mary Keller to serve as vice president of clinical operations. Before joining Sequenom, Keller was VP of global clinical development for Shire Pharmaceuticals, and head of development operations and clinical trial recruitment services for Pfizer global R&D.


Svilen Tzonev has been named head of informatics at Department of Energy's Joint Genome Institute in Walnut Creek, Calif.

He was formerly at Illumina, where he was the senior director of software, bioinformatics, and IT and helped to develop and commercialize the Genome Analyzer system. Prior to that post, he was director of software and informatics at GE Healthcare and Amersham Pharmacia Biotech, where he led development of sequencing, genotyping, gene-expression, and cellular-screening systems and applications.

He has also held positions at Molecular Dynamics and KLA-Tencor in project management and system engineering roles.

He holds a PhD in physics from the University of Illinois at Urbana-Champaign and was a Keck postdoctoral fellow in theoretical neurobiology at the University of California at San Francisco Medical School.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.